ADVAXIS, INC. (NASDAQ:ADXSD) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
A copy of the press release of Advaxis, Inc. (the Company) dated
January 9, 2017 relating to the announcement discussed in Item
8.01 below is attached hereto as Exhibit 99.1.
The information furnished to this Item 7.01, including Exhibit
99.1, shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934 (the Exchange Act) or otherwise
subject to the liabilities under that Section and shall not be
deemed to be incorporated by reference into any filing of the
Company under the Securities Act of 1933 or the Exchange Act,
except as shall be expressly set forth by specific reference in
such filing.
Item 8.01 Other Events.
On January 9, 2017, the Company announced its business outlook
for 2017, including clinical development and expanding pipeline
milestones.
Item 9.01. Financial Statements and Exhibits.
| (d) | Exhibits. |
The following exhibit is furnished as a part of this report
| 99.1 | Press Release dated January 9, 2017. |